financetom
Business
financetom
/
Business
/
Moderna Wins UK Patent Dispute Against Pfizer, BioNTech
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Moderna Wins UK Patent Dispute Against Pfizer, BioNTech
Aug 1, 2025 4:26 AM

07:00 AM EDT, 08/01/2025 (MT Newswires) -- Moderna ( MRNA ) said Friday that the UK Court of Appeal has upheld the validity of its EP'949 patent, affirming an earlier court ruling that the patent was infringed by Pfizer ( PFE ) and BioNTech's (BNTX) Comirnaty COVID-19 vaccine.

The company said the patent covers one of its "foundational technologies that enables the development of mRNA-based medicines."

Pfizer ( PFE ) and BioNTech did not immediately respond to MT Newswires' requests for comments.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Market Chatter: Sapiens in Talks to Sell Controlling Stake to US Investment Funds At $2 Billion Valuation
Market Chatter: Sapiens in Talks to Sell Controlling Stake to US Investment Funds At $2 Billion Valuation
Aug 11, 2025
09:15 AM EDT, 08/11/2025 (MT Newswires) -- Sapiens International ( SPNS ) is in talks to sell a controlling stake to US investment funds at a valuation of $2 billion to $2.2 billion, tech news website CTech said Monday, citing a senior Sapiens executive. The talks are in final stage, and if the parties sign a deal within the next...
Quantum BioPharma Signs Deal to Manufacture Oral Drug Formula of Lucid-MS for Multiple Sclerosis
Quantum BioPharma Signs Deal to Manufacture Oral Drug Formula of Lucid-MS for Multiple Sclerosis
Aug 11, 2025
09:14 AM EDT, 08/11/2025 (MT Newswires) -- Quantum BioPharma ( QNTM ) said Monday it has signed a deal, through its Huge Biopharma Australia unit, with an unnamed contract development and manufacturing organization to manufacture an oral drug formulation of Lucid-MS. The company will use the oral formulation of Lucid-MS, a non-immunomodulatory, neuroprotective compound, in its upcoming phase 2 multiple...
Global Payments Selected as Payments Provider by Tampa Bay Lightning
Global Payments Selected as Payments Provider by Tampa Bay Lightning
Aug 11, 2025
09:14 AM EDT, 08/11/2025 (MT Newswires) -- Global Payments ( GPN ) said Monday it has been selected as payments provider by National Hockey League's Tampa Bay Lightning. The deal covers food and beverage, retail, and ticketing transactions, including all events at Amalie Arena in Tampa, Florida, the company said. Financial terms of the deal were not disclosed. ...
Copyright 2023-2025 - www.financetom.com All Rights Reserved